Industry

DUBLIN–(BUSINESS WIRE)–The “Childhood Absence Epilepsy Treatment Market Research Report by Drug (Lamotrigine, Phase 2 Drugs, and Valproate), Disease Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Childhood Absence Epilepsy Treatment Market size was estimated … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Acne Drugs Market Research Report by Acne Type (Comedonal, Cystic, and Inflammatory), Drug Class, Drug Type, Route of Administration, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Acne Drugs Market size was estimated at USD 1,119.50 million in 2021, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Monoclonal Antibodies for Oncology: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market’s drivers, challenges, and … [Read more…]

WASHINGTON–(BUSINESS WIRE)–#FacesofAcceleratedApproval–The Partnership to Fight Chronic Disease (PFCD) released the following statement today regarding the Prescription Drug Pricing Reform proposal aiming to lower drug prices through government negotiation under Medicare: “More than half of U.S. adults are living with at least one chronic condition and four in ten adults live with two or more. For … [Read more…]

WHITE PLAINS, N.Y.–(BUSINESS WIRE)–The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its second quarter 2022 financial results on Monday, August 8, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T. Conference … [Read more…]

Aural Analytics’ Speech Vitals technology delivers clinical-grade speech analytics PHOENIX–(BUSINESS WIRE)–#AuralAnalytics–Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today it was awarded a $1.4 million grant from the National Institutes of Health. The grant supports Aural Analytics’ development of a tool speech-language pathologists can use to improve their clinical workflow. “The timing of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Fractional Flow Reserve Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing stent insertion, … [Read more…]

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that it has made an amendment to the terms of the non-brokered Private Placement previously announced in its News Release dated June 30, 2022. The private placement is being offered to accredited investors to raise up to $4 million … [Read more…]

SG Blocks and Clarity Lab Solutions joint venture, Clarity Mobile Venture, received an extension for COVID-19 testing at its Los Angeles International Airport location. JACKSONVILLE, Fla.–(BUSINESS WIRE)–SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading developer, designer, and fabricator of modular structures, announced today that Clarity Mobile Venture, a partnership with Clarity … [Read more…]